Showing results (1-10 of 64) with videos related to
Sort By:
Pageof 7
Molecular Medicine Reports|November 15, 2016
Changes in enteroendocrine and immune cells following colitis induction by TNBS in ratsMagdy El-Salhy, Jan Gunnar HatlebakkDigestive Diseases and Sciences|March 6, 2024
Factors Underlying the Difference in Response to Fecal Microbiota Transplantation Between IBS Patients with Severe and Moderate SymptomsMagdy El-Salhy, Jan Gunnar HatlebakkNutrients|August 10, 2019
Diet in Irritable Bowel Syndrome (IBS): Interaction with Gut Microbiota and Gut HormonesMagdy El-Salhy, Jan Gunnar Hatlebakk, Trygve HauskenNeuropeptides|November 16, 2019
Possible role of peptide YY (PYY) in the pathophysiology of irritable bowel syndrome (IBS)Magdy El-Salhy, Jan Gunnar Hatlebakk, Trygve HauskenMolecular Medicine Reports|September 18, 2020
Density of Musashi‑1‑positive stem cells in the stomach of patients with irritable bowel syndromeMagdy El-Salhy, Trygve Hausken, Jan Gunnar HatlebakkNutrients|June 27, 2019
Increasing the Dose and/or Repeating Faecal Microbiota Transplantation (FMT) Increases the Response in Patients with Irritable Bowel Syndrome (IBS)Magdy El-Salhy, Trygve Hausken, Jan Gunnar HatlebakkNeurogastroenterology and Motility|July 8, 2021
Current status of fecal microbiota transplantation for irritable bowel syndromeMagdy El-Salhy, Trygve Hausken, Jan Gunnar HatlebakkWorld Journal of Gastroenterology|September 2, 2015
Reduction in duodenal endocrine cells in irritable bowel syndrome is associated with stem cell abnormalitiesMagdy El-Salhy, Jan Gunnar Hatlebakk, Trygve HauskenMolecular Medicine Reports|June 11, 2019
Overlapping of irritable bowel syndrome with erosive esophagitis and the performance of Rome criteria in diagnosing IBS in a clinical settingMagdy El-Salhy, Odd Helge Gilja, Jan Gunnar HatlebakkWorld Journal of Gastroenterology|January 10, 2009
Mucosal blood flow measurements using laser Doppler perfusion monitoringDag Arne Lihaug Hoff, Hans Gregersen, Jan Gunnar HatlebakkPageof 7